Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease


Authors: M. Meyer, E. Huang, O. Yuzhakov, P. Ramanathan, G. Ciaramella and A. Bukreyev

Journal: Journal of Infectious Diseases

DOI: 10.1093/infdis/jix592

Publication - Abstract

December 21, 2017

Vaccines Nucleic Acid Lipid Nanoparticles mRNA

Abstract

Most current Ebola virus (EBOV) vaccine candidates are based on viral vectors, some of which cause side effects or require complex manufacturing. Modified mRNA vaccines are easily produced, safe, and are highly immunogenic. We developed 2 mRNA vaccines based on the EBOV envelope glycoprotein, which differed by the nature of signal peptide for improved glycoprotein post-translational translocation. The mRNAs were formulated with lipid nanoparticles to facilitate delivery. Vaccination of guinea pigs induced EBOV-specific IgG and neutralizing antibody responses and 100% survival after EBOV infection. The efficacy of our mRNA vaccine combined with preclinical safety data supports testing in clinical studies.


limit search to this category
Advanced Search

Advanced Search

close
  • Publications
  • Application Notes
  • Posters
  • Workshops
  • Videos & Webinars
  • Articles
Search

Browse by Category

  • Application
    • Diagnostic and Imaging
    • Genetic Medicine
    • Hematology
    • Metabolic Disorders
    • Neuroscience
    • Oncology
    • Skeletal Disorders
    • Targeted Drug Delivery
    • Vaccines
    • Other Applications
    • Cell therapy
  • Formulation
    • Liposomes
    • Nucleic Acid Lipid Nanoparticles
    • Polymeric Nanoparticles
    • Other Formulations
  • Payload
    • DNA
    • microRNA
    • mRNA
    • siRNA
    • Small Molecule Drugs
    • Other Payloads


related content

Publication - Abstract

Dec 31, 2019
Vaccines

Investigating Prime-Pull Vaccination through a Combination of Parenteral Vaccination and Intranasal Boosting

C.B. Roces, M.T. Hussain, S.T. Schmidt, D. Christensen and Y. Perrie

Other Payloads Polymeric Nanoparticles Vaccines
Scientists from the Institute of Pharmacy and Biomedical Science at the University of Strathclyde confirm the ability of PLGA polymeric nanoparticles in a dry powder form to successfully deliver an encapsulated antigen payload intranasally for uptake in cells residing in the deep...
Read More


Publication - Abstract

Feb 04, 2020
npj Vaccines

The Promise of mRNA Vaccines: A Biotech and Industrial Perspective

N.A.C Jackson, K.E. Kester, D. Casimiro, S. Gurunathan and F. DeRosa

Vaccines Nucleic Acid Lipid Nanoparticles mRNA
mRNA technologies have the potential to transform areas of medicine, including the prophylaxis of infectious diseases. The advantages for vaccines range from the acceleration of immunogen discovery to rapid response and multiple disease target manufacturing. A greater understandi...
Read More


Sign Up and Stay Informed
Sign up today to automatically receive new Cytiva, formerly Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.
Sign Up